Welcome to our dedicated page for Definitive Healthcare SEC filings (Ticker: DH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Finding churn rates, data acquisition costs, or insider sentiment in Definitive Healthcare’s dense disclosures can feel like searching for a single ICD-10 code in a sea of claims. Stock Titan surfaces the signal you need—fast. Whether you’re tracking Definitive Healthcare insider trading Form 4 transactions or deciphering a 300-page MD&A, the complexity of a healthcare data-as-a-service model makes traditional document dives time-consuming.
Our platform solves that. AI parses every Definitive Healthcare quarterly earnings report 10-Q filing, highlights ARR growth, and links segment commentary to KPIs. Real-time alerts flag Definitive Healthcare Form 4 insider transactions real-time, while natural language summaries offer Definitive Healthcare SEC filings explained simply. You’ll see side-by-side Definitive Healthcare earnings report filing analysis and peer comps without touching a spreadsheet.
What can you explore today?
- Growth metrics unlocked: our AI guides you in understanding Definitive Healthcare SEC documents with AI, extracting subscriber counts, retention rates, and data-licensing revenue deep inside footnotes.
- Governance clarity: the latest Definitive Healthcare executive stock transactions Form 4 and Definitive Healthcare proxy statement executive compensation filings reveal how leadership incentives align with market expansion.
- Event impact: receive instant context when a new partner agreement drops via an Definitive Healthcare 8-K material events explained alert.
- Year-end deep dives: get the Definitive Healthcare annual report 10-K simplified into bullet-ready takeaways in minutes.
From segment analytics to acquisition spend, Stock Titan’s AI turns Definitive Healthcare filings into actionable insight—so you can focus on decisions, not page counts.
Definitive Healthcare Corp. reported Q3 2025 revenue of $60.0 million versus $62.7 million a year ago, with gross profit of $46.0 million. Loss from operations was $8.7 million. Net loss attributable to Definitive Healthcare narrowed to $14.8 million from $130.9 million in Q3 2024, which included a large impairment.
Year to date, revenue was $180.0 million and operating cash flow was $51.1 million. The company reduced its 2021 Term Loan principal to $168.4 million and had no borrowings on its $50.0 million revolver, with $49.7 million available after a standby letter of credit. Total assets were $755.5 million, including goodwill of $216.8 million following a $176.5 million non‑cash goodwill impairment recorded in Q1 2025. Deferred revenue was $92.0 million, and remaining performance obligations totaled $247.3 million. Class A shares outstanding were 103,011,649 as of September 30, 2025.
Definitive Healthcare Corp. (DH) reported a filing action. The company furnished an Item 2.02 Form 8‑K to announce it issued a press release with financial results for the third quarter ended September 30, 2025. The press release is included as Exhibit 99.1. The company states the information in Item 2.02 and Exhibit 99.1 is being furnished, not filed, and is not subject to Section 18 liabilities nor incorporated by reference into other filings.
Definitive Healthcare Corp. (DH) disclosed an insider transaction by its Chief Financial Officer on a Form 4. On 11/01/2025, the CFO had 1,244 shares of Class A common stock withheld at $2.77 per share under transaction code F, which indicates shares were withheld to cover taxes on vested restricted stock units. Following this administrative withholding, the officer beneficially owns 1,080,177 shares directly. The footnote confirms the activity was tied to the vesting and settlement of previously reported RSUs.
Definitive Healthcare (DH) reported an insider transaction by its Executive Chairman and Director. On 11/01/2025, 18,796 shares of Class A common stock were withheld by the company at $2.77 per share to cover tax obligations upon the vesting and settlement of previously reported RSUs. Following this administrative transaction, the reporting person beneficially owns 1,060,584 shares directly and 450,000 shares indirectly through DH Holdings (f/k/a Jason R. Krantz 2009 Trust), of which he is the beneficiary.
Definitive Healthcare Corp. reporting person Casey Heller, the company's Chief Financial Officer, disclosed a transaction on 10/01/2025 in which 8,300 shares of Class A common stock were disposed of at $3.56 per share. After the reported sale, the filing shows the reporting person beneficially owns 1,081,421 shares. The form explains the transaction reflects shares withheld by the issuer to satisfy the reporting person’s tax withholding obligations related to the vesting and settlement of previously reported restricted stock units. The filing is an individual Form 4 and was signed by an attorney-in-fact on behalf of the reporting person.
Kevin Coop, who is listed as both Chief Executive Officer and a Director of Definitive Healthcare Corp. (DH), reported a transaction on 10/01/2025. The report shows a Code F(1) transaction disposing of 37,593 shares of Class A common stock at a price of $3.56 per share. The filing explains these shares were withheld by the issuer to satisfy the reporting person’s tax withholding obligations related to the vesting and settlement of previously reported restricted stock units. After the withholding, the reporting person beneficially owned 3,584,788 shares, held directly. The form is signed by an attorney-in-fact on behalf of the reporting person on 10/03/2025.
Definitive Healthcare Corp. (DH) insider Jason R. Krantz reported a transaction on 09/14/2025. The filing shows a disposition of 4,093 shares of Class A common stock at $4.15 per share, recorded as a sale to satisfy tax withholding related to vested restricted stock units. After the transaction, Mr. Krantz directly beneficially owns 1,079,380 shares and indirectly owns 450,000 shares held in trust by DH Holdings (formerly the Jason R. Krantz 2009 Trust). The filing was signed by an attorney-in-fact on 09/16/2025.
On 08/01/2025, Definitive Healthcare Corp. (DH) Chief Financial Officer Casey Heller filed a Form 4 reporting a routine tax-withholding transaction. The company withheld 1,244 Class A common shares (transaction code F) at an implied price of $3.74 per share to cover federal taxes triggered by the vesting of previously granted restricted stock units. Following the withholding, Heller still directly owns 1,089,721 shares, preserving the vast majority of his stake. No open-market purchase or discretionary sale occurred, and there were no derivative security movements disclosed. The filing is administrative in nature and does not indicate a change in role, outlook, or insider sentiment.
Form 4 filed 08/05/2025 discloses that Definitive Healthcare (DH) Chief Operating Officer Kate Marie Shamsuddin satisfied tax-withholding obligations from previously granted restricted stock units. On 08/01/2025 she surrendered 4,741 Class A common shares to the issuer at an imputed price of $3.74; no cash was received. The transaction is coded “F,” indicating share withholding rather than an open-market sale.
After the withholding, Shamsuddin directly owns 694,149 DH shares. No derivative securities were acquired or disposed of, and no additional insider transactions were reported. The surrendered shares equal roughly 0.7 % of her post-transaction holdings, suggesting minimal impact on insider ownership concentration or public float.
FAQ
What is the current stock price of Definitive Healthcare (DH)?
What is the market cap of Definitive Healthcare (DH)?
